Arkolith/Insider Trading/IMPL/Form 4

Shrewsbury Stephen B

Chief Medical OfficerIMPEL NEUROPHARMA INC (IMPL) · full profile →Form 4 · filed Sep 22, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 21, 2021Option exercise(M)54K$2.95$159K73K
Sep 21, 2021Option exercise(M)5K$2.46$11K19K
Sep 21, 2021Option exercise(M)15K$1.97$29K15K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 21, 2021Option exercise(M)54K—$030K
Sep 21, 2021Option exercise(M)5K—$0541
Sep 21, 2021Option exercise(M)15K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-057275) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML